Profile

Nemesis Bioscience

Nemesis Bioscience was founded in 2014 to address the global threat posed by increasing bacterial resistance to commonly used antibiotics.

Nemesis will commercialise inventions to make existing antibiotics effective once more by not only overcoming resistant bacterial infections but also by preventing them in susceptible patients.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.nemesisbio.com

Associated Team Members

Relevant News

Nemesis Bioscience Closes Funding Round And Begins Preclinical Programmes

Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total seed…

read more

NEMESIS BIOSCIENCE WINS INNOVATE UK SBRI FUNDING AWARD

Nemesis Bioscience has been successful in winning a £414, 000 award granted by the...

read more

NEMESIS BIOSCIENCE EXPANDS DEVELOPMENT FACILITY IN ABERYSTWYTH

Nemesis Bioscience today announced the expansion of its presence in Aberystwyth by opening a...

read more

LEADING PHARMACEUTICAL EXECUTIVE JOINS NEMESIS BIOSCIENCE

New Chairman Brings “Wealth of Experience” to Pioneering Biotech Firm Simon Sturge, Executive Vice President...

read more

More Companies in Medical / Biotechnology